David Strain,MD, FRCP, associate professor of cardiometabolic health at the University of Exeter Medical School in the United Kingdom, similarly not involved in the study, explained that: GLP-1 receptor antagonists and SGLT-2 inhibitors have been demonstrated to control the sugar, and also reduce the inflammation (a key driver of Alzheimers disease) and reduce vascular risk (a key driver of vascular dementia) more than would be expected by the sugar control alone. It is therefore no surprise that these data show a lower risk of dementia in people who receive them as part of her routine care, Strain continued
I have to start by apologizing for taking this long to write on a topic that is of great interest to my client base and the public at large hypothyroidism
Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study
Rybelsus is a Semaglutide specifically designed to improve blood sugar levels in individuals diagnosed with type 2 diabetes
Careful nutritional assessment, hydration and electrolyte replenishment are a priority
